Elicio Therapeutics (ELTX) Cash & Equivalents (2020 - 2026)
Elicio Therapeutics (ELTX) reported Cash & Equivalents of $23.5 million for Q2 2026, up 6.4% from $22.09 million a year earlier and up 57.2% from the prior quarter.
Elicio Therapeutics (ELTX) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Elicio Therapeutics posted Cash & Equivalents of $18.56 million, up 5.4% from FY2024.
- Cash & Equivalents has increased for three consecutive years, though with a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $17.62 million in FY2024 (+36.6%), $12.89 million in FY2023 (+109.5%), $6.16 million in FY2022 (-93.1%) and $88.76 million in FY2021 (+156.5%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents since Q3 2024.
- Year over year, Cash & Equivalents gained in six of the last eight quarters, with growth averaging 85.5%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2023 (growth of 707.0%); the low point was Q2 2022 (a decline of 99.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14.95 million (Q1 2026), $18.56 million (Q4 2025) and $20.61 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.76 Bn | 1,103.34 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 634.69 Bn | 554.55 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 506.51 Bn | 479.62 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 357.95 Bn | 312.33 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 293.14 Bn | 257.13 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.38 Bn | 239.06 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 238.37 Bn | 193.77 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.16 Bn | 169.36 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 170.88 Bn | 117.53 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Elicio Therapeutics | 37.05 Mn | -40.58 Mn | - | 23.50 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.50 Mn |
| Mar 31, 2026 | 14.95 Mn |
| Dec 31, 2025 | 18.56 Mn |
| Sep 30, 2025 | 20.61 Mn |
| Jun 30, 2025 | 22.09 Mn |
| Mar 31, 2025 | 18.35 Mn |
| Dec 31, 2024 | 17.62 Mn |
| Sep 30, 2024 | 26.02 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 11.85 Mn |
| Dec 31, 2023 | 12.89 Mn |
| Sep 30, 2023 | 14.84 Mn |
| Jun 30, 2023 | 21.68 Mn |
| Mar 31, 2023 | 8.57 Mn |
| Dec 31, 2022 | 6.16 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 598,000.00 |
| Mar 31, 2022 | 73.00 Mn |
| Dec 31, 2021 | 88.76 Mn |
| Sep 30, 2021 | 102.74 Mn |
Elicio Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ELTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ELTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ELTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();